PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 106 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q2 2017. The put-call ratio across all filers is 112.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $704,000 | -47.9% | 267,000 | -29.7% | 0.04% | -54.2% |
| Q2 2017 | $1,352,000 | +298.8% | 379,800 | +325.3% | 0.08% | +196.4% |
| Q4 2016 | $339,000 | -1.2% | 89,300 | -5.2% | 0.03% | -37.8% |
| Q3 2015 | $343,000 | -62.6% | 94,200 | -40.9% | 0.04% | -64.8% |
| Q2 2015 | $916,000 | -33.6% | 159,400 | -32.7% | 0.13% | -33.7% |
| Q1 2015 | $1,379,000 | -34.8% | 236,700 | -12.3% | 0.19% | -45.8% |
| Q4 2014 | $2,116,000 | +46.5% | 269,900 | -8.4% | 0.36% | +64.1% |
| Q3 2014 | $1,444,000 | -37.8% | 294,700 | -22.0% | 0.22% | -37.1% |
| Q2 2014 | $2,322,000 | -18.1% | 377,600 | -28.6% | 0.34% | -21.8% |
| Q1 2014 | $2,835,000 | +246.6% | 529,100 | +238.1% | 0.44% | +210.6% |
| Q4 2013 | $818,000 | -14.9% | 156,500 | -10.3% | 0.14% | -35.5% |
| Q3 2013 | $961,000 | +284.4% | 174,500 | +75.7% | 0.22% | +228.4% |
| Q2 2013 | $250,000 | – | 99,300 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 1,446,459 | $48,182,000 | 7.22% |
| BOURNE LENT ASSET MANAGEMENT INC | 536,800 | $17,881,000 | 5.70% |
| Casdin Capital, LLC | 5,000,000 | $166,550,000 | 4.96% |
| Iron Triangle Partners LP | 935,805 | $31,172,000 | 3.96% |
| Jackson Square Partners, LLC | 12,911,695 | $430,088,000 | 2.44% |
| SB Management Ltd | 9,861,089 | $328,473,000 | 2.12% |
| Abacus Planning Group, Inc. | 180,000 | $5,996,000 | 1.92% |
| BERKSHIRE CAPITAL HOLDINGS INC | 413,800 | $13,784,000 | 1.57% |
| ARK Investment Management | 21,301,191 | $709,543,000 | 1.41% |
| Nikko Asset Management Americas, Inc. | 5,247,237 | $174,785,000 | 0.86% |